Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (12)
Positron emission tomography/computed tomography (PET/CT) (7)
Tuberculosis (TB) (7)
Prostate-specific membrane antigen (PSMA) (6)
Infection (5)
PET/CT (5)
Computed tomography (CT) (4)
Prostate cancer (4)
South Africa (SA) (4)
Cancer (3)
Nuclear medicine (3)
Patients (3)
177Lu-PSMA (2)
68Ga-PSMA (2)
Antimicrobial peptide (AMP) (2)
Biodistribution (2)
Case report (2)
Computerized tomography (CT) (2)
Diagnosis (2)
FDG PET (2)
HIV infection (2)
HIV/AIDS (2)
Invasive fungal infection (IFI) (2)
Invasive fungal infections (2)
Molecular imaging (2)
NODAGA (2)
Patient management (2)
Prostate carcinoma (2)
Radiopharmaceuticals (2)
SPECT (2)
Theranostics (2)
Therapy monitoring (2)
Total lesion glycolysis (TLG) (2)
Treatment (2)
Ubiquicidin (2)
18F- (1)
18F-FDG (1)
18F-FDG imaging (1)
18F-FDG PET/CT (1)
18F-fluorodeoxyglucose (18F-FDG) (1)
18Ffluorodeoxyglucose (FDG) (1)
195mPt-cisplatinum (1)
2-Fluorodeoxy-D-glucose imaging (1)
2-fluorodeoxyglucose positron emission tomography integrated with CT (FDG-PET/CT) (1)
68Ga (1)
68Ga labeling (1)
68Ga-citrate (1)
68Ga-citrate PET/CT (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMA PET/CT (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
68Ga‐PSMA‐617 (1)
99mTc-UBI 29-41 (1)
Accountability (1)
Actinium-225 (1)
Active ingredients (1)
Adult (1)
AIDS (Disease) (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (1)
Antifungal therapy (1)
Antimicrobial peptides (1)
Aspergillus (1)
Bacteria (1)
Bacterial infections (1)
Behandlung (1)
Bins (1)
Bioassay (1)
Biomaterials (1)
Bisphosphonates (1)
Black South-African (BSAs) (1)
Blood-brain barrier (1)
Blood-brain barrier (BBB) (1)
Blood–brain barrier (BBB) (1)
Bone metastases (1)
Bone SPECT-CT (1)
Breast cancer (1)
Breast uptake (1)
Brown adipose tissue (BAT) (1)
Brown fat (1)
Burkitt lymphoma (BL) (1)
Calcium (1)
Cancer -- Patients -- Care (1)
Candida (1)
Carcinoma (1)
CAS 82626-48-0 (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
Cavernous sinus syndrome (1)
CDP1 (1)
Cervical cancer (1)
Cervix (1)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)